Approval for the orthovisc high molecular weight hyaluronan. The device is indicated fo the treatment of pain in osteoarthritis (oa) of the knee in patients who have failed to respond adequately to conservative non-pharmacologic therapy and to simple analgesics (e. G. , acetaminophen).
Device | ORTHOVISC HIGH MOLECULAR WEIGHT HYALURONAN |
Classification Name | Acid, Hyaluronic, Intraarticular |
Generic Name | Acid, Hyaluronic, Intraarticular |
Applicant | Anika Therapeutics, Inc. |
Date Received | 2003-05-30 |
Decision Date | 2004-02-04 |
Notice Date | 2006-08-24 |
PMA | P030019 |
Supplement | S |
Product Code | MOZ |
Docket Number | 06M-0339 |
Advisory Committee | Orthopedic |
Expedited Review | No |
Combination Product | No |
Applicant Address | Anika Therapeutics, Inc. 32 Wiggins Avenue bedford, MA 01730 |
Summary: | Summary of Safety and Effectiveness |
Labeling: | Labeling Labeling Part 2 |
Approval Order: | Approval Order |
Supplemental Filings
Supplement Number | Date | Supplement Type |
P030019 | | Original Filing |
S027 |
2022-10-12 |
30-day Notice |
S026 |
2020-12-30 |
135 Review Track For 30-day Notice |
S025 |
2020-11-09 |
30-day Notice |
S024 | | |
S023 |
2016-02-10 |
Special (immediate Track) |
S022 |
2014-12-24 |
135 Review Track For 30-day Notice |
S021 |
2014-06-25 |
30-day Notice |
S020 |
2014-06-10 |
30-day Notice |
S019 |
2014-05-15 |
30-day Notice |
S018 |
2011-08-24 |
135 Review Track For 30-day Notice |
S017 |
2010-11-03 |
135 Review Track For 30-day Notice |
S016 | | |
S015 |
2010-06-09 |
30-day Notice |
S014 |
2009-06-16 |
Normal 180 Day Track No User Fee |
S013 |
2006-07-24 |
135 Review Track For 30-day Notice |
S012 |
2006-08-09 |
Normal 180 Day Track |
S011 | | |
S010 |
2006-07-10 |
30-day Notice |
S009 |
2006-04-28 |
Normal 180 Day Track |
S008 |
2006-01-03 |
30-day Notice |
S007 | | |
S006 |
2004-07-01 |
Normal 180 Day Track |
S005 |
2004-06-17 |
30-day Notice |
S004 |
2004-05-07 |
30-day Notice |
S003 |
2004-03-16 |
30-day Notice |
S002 | | |
S001 |
2004-02-27 |
135 Review Track For 30-day Notice |
NIH GUDID Devices